Adaptive Trial Designs: Maximizing the Opportunity for Success in Drug Development
Friday, October 19, 2018
MassBio 300 Technology Square, 8th Floor Cambridge, MA 11:00 AM to 1:00 PM
How can you improve the success rate in drug development? Understanding the use of adaptive trial designs during the development program, from first in human studies to pivotal Phase III studies, is imperative to achieving set goals. PAREXEL will be hosting a discussion focused on the critical success factors in the planning, implementation and execution of adaptive trial designs.
Topics will include:
Background and regulatory view of adaptive trial designs
Challenges for the implementation of adaptive trial designs
Types of adaptive trial designs
Components of successful implementation
Real-world case studies
Understanding the opportunities associated with adaptive trial designs will help you make better decisions during drug development and improve the probability of success to bring treatment options to patients faster while controlling budget targets. Come prepared with your questions!
Featured PAREXEL speakers:
Martin Roessner, Corporate Vice President, Biostatistics, PAREXEL International
Brad Gillespie, Principal Regulatory Consultant, PAREXEL International
Agenda
10:30 AM
Registration Opens
11:00 AM
Presentation
11:45 AM
Q&A
12:00 PM
Networking Lunch
01:00 PM
Program Close
Would you like to hear from us in the future?
Note: You will be registered for this event and receive event-related emails regardless of your selection.
Please select any one option.
Yes, I would like to receive marketing communications including industry insights and trends from PAREXEL International.
